NO20020835L - Blandinger for inhalering omfattende delta-9- tetrahydrokannabinol i et semivandig lösningsmiddel - Google Patents

Blandinger for inhalering omfattende delta-9- tetrahydrokannabinol i et semivandig lösningsmiddel

Info

Publication number
NO20020835L
NO20020835L NO20020835A NO20020835A NO20020835L NO 20020835 L NO20020835 L NO 20020835L NO 20020835 A NO20020835 A NO 20020835A NO 20020835 A NO20020835 A NO 20020835A NO 20020835 L NO20020835 L NO 20020835L
Authority
NO
Norway
Prior art keywords
tetrahydrocannabinol
delta
semi
aqueous solvent
inhalation
Prior art date
Application number
NO20020835A
Other languages
English (en)
Other versions
NO20020835D0 (no
Inventor
Andrea M Mcphillips
Julia J Economou
Mahendra G Dedhiya
Beverly Ann Wynne
Original Assignee
Unimed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals Inc filed Critical Unimed Pharmaceuticals Inc
Publication of NO20020835D0 publication Critical patent/NO20020835D0/no
Publication of NO20020835L publication Critical patent/NO20020835L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO20020835A 1999-08-20 2002-02-20 Blandinger for inhalering omfattende delta-9- tetrahydrokannabinol i et semivandig lösningsmiddel NO20020835L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15002399P 1999-08-20 1999-08-20
PCT/US2000/022495 WO2001013886A1 (en) 1999-08-20 2000-08-15 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent

Publications (2)

Publication Number Publication Date
NO20020835D0 NO20020835D0 (no) 2002-02-20
NO20020835L true NO20020835L (no) 2002-04-02

Family

ID=22532791

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020835A NO20020835L (no) 1999-08-20 2002-02-20 Blandinger for inhalering omfattende delta-9- tetrahydrokannabinol i et semivandig lösningsmiddel

Country Status (14)

Country Link
EP (1) EP1212039B1 (no)
JP (1) JP2003535813A (no)
CN (1) CN1187093C (no)
AT (1) ATE308314T1 (no)
AU (1) AU779324B2 (no)
CA (1) CA2382217A1 (no)
DE (1) DE60023720T2 (no)
DK (1) DK1212039T3 (no)
ES (1) ES2246883T3 (no)
IL (2) IL148241A0 (no)
MX (1) MXPA02001804A (no)
NO (1) NO20020835L (no)
NZ (1) NZ517517A (no)
WO (1) WO2001013886A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7648696B2 (en) 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
GB2361869B (en) * 2000-03-09 2004-09-22 Pharmasol Ltd Sublingual delivery of cannabis
ATE353629T1 (de) 2000-03-09 2007-03-15 Gw Pharma Ltd Cannabis enthaltende pharmazeutische zusammensetzungen
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
SI1542657T1 (sl) * 2002-08-14 2012-04-30 Gw Pharma Ltd Kanabinoidne kapljevite formulacije za sluzniäśno administracijo
CN102766128A (zh) 2005-09-29 2012-11-07 阿尔巴尼分子研究公司 δ-9-四氢大麻酚的生成方法
GB2431105A (en) 2005-10-12 2007-04-18 Gw Pharma Ltd Cannabinoids for the treatment of pulmonary disorders
GB2524469A (en) 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
CA2950424C (en) * 2014-05-29 2023-03-14 Insys Pharma, Inc. Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US12544389B2 (en) 2014-05-29 2026-02-10 Fresh Cut Development, Llc Stable cannabinoid formulations
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US10610512B2 (en) 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
CN110200953B (zh) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 大麻素在制备吸入给药药物中的应用
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
DK1212039T3 (da) 2005-12-19
AU779324B2 (en) 2005-01-20
WO2001013886A1 (en) 2001-03-01
DE60023720T2 (de) 2006-07-20
JP2003535813A (ja) 2003-12-02
NO20020835D0 (no) 2002-02-20
DE60023720D1 (de) 2005-12-08
NZ517517A (en) 2004-03-26
CN1420761A (zh) 2003-05-28
IL148241A (en) 2007-02-11
HK1056318A1 (en) 2004-02-13
MXPA02001804A (es) 2004-09-06
CN1187093C (zh) 2005-02-02
ES2246883T3 (es) 2006-03-01
IL148241A0 (en) 2002-09-12
CA2382217A1 (en) 2001-03-01
ATE308314T1 (de) 2005-11-15
AU6910700A (en) 2001-03-19
EP1212039B1 (en) 2005-11-02
EP1212039A1 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
NO20020835L (no) Blandinger for inhalering omfattende delta-9- tetrahydrokannabinol i et semivandig lösningsmiddel
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
US4912124A (en) Antifungal dermatological solution
KR950007858A (ko) 정맥내 주사용 라파마이신 제형
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
RU2003132426A (ru) Фармацевтический раствор арипипразола для орального применения
NO952269L (no) Stabiliserte medisinske aerosollösnings-formuleringer
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
CA2215327A1 (en) Formulations for lipophilic compounds
AR085989A2 (es) Composiciones endoparasiticidas y proceso para su preparacion
AR034370A1 (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
ES2058228T3 (es) Compuestos activos sobre el sistema cardiovascular.
EA200702593A1 (ru) Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами
WO2005007129A3 (en) Topical formulations with bioactive components
SE9900177L (sv) Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
ATE65400T1 (de) Arzneimittelformulierung.
DE69529079D1 (de) Codein enthaltende formulierungen
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
RU2003106170A (ru) Противопаразитарные препараты для безыгольного введения
KR930004460A (ko) 에이(a) 87689 화합물
Hsu et al. The Studies on The Stable Vitamin BC Complex Parenteral Formulation, I. The Solution Phase Stability of I-Ascorbic Acid as Function of pH and Dielectric Constant in Anaerobic Conditon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application